Bank of America Corporation (BofA) has announced the pricing of its Capped Enhanced Return Notes linked to the common stock of Bristol-Myers Squibb Company, with a maturity date of December 31, 2026. The notes, which are due to be issued on June 28, 2024, offer investors exposure to the stock performance of Bristol-Myers Squibb, with a maximum return of 90.50%. The notes were priced on June 26, 2024, with an approximate term of 2.5 years, and the starting value was determined on June 25, 2024. Payments on the notes are contingent on the performance of Bristol-Myers Squibb's stock, with the potential for investors to receive up to 300.00% of any increase in the stock's value, subject to the capped return. If the stock's value declines...Show More

Bank of America Corporation (BofA) has announced the pricing of its Capped Enhanced Return Notes linked to the common stock of Bristol-Myers Squibb Company, with a maturity date of December 31, 2026. The notes, which are due to be issued on June 28, 2024, offer investors exposure to the stock performance of Bristol-Myers Squibb, with a maximum return of 90.50%. The notes were priced on June 26, 2024, with an approximate term of 2.5 years, and the starting value was determined on June 25, 2024. Payments on the notes are contingent on the performance of Bristol-Myers Squibb's stock, with the potential for investors to receive up to 300.00% of any increase in the stock's value, subject to the capped return. If the stock's value declines by more than 20% from its starting value, investors' principal is at risk. The notes, which will not pay periodic interest, are not FDIC insured, are not bank guaranteed, and may lose value. They will not be listed on any securities exchange. The initial estimated value of the notes is $963.10 per $1,000.00 in principal amount, which is less than the public offering price. The notes are subject to the credit risk of both BofA Finance LLC, as the issuer, and Bank of America Corporation, as the guarantor. The public offering price per note is $1,000.00, with an underwriting discount of $5.00, resulting in proceeds before expenses to BofA Finance of $995.00 per note.